Natural Product: NPC469419

Natural Product IDNPC469419
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Paeonidanin C
IUPAC Name n.a.
Synonyms paeonidanin C
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1078414
PubChem CID 46883513
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PBDROKLULCIDPL-WNKDLFHOSA-N
Standard InCHI InChI=1S/C31H34O13/c1-29-13-20(33)19-12-31(29,30(19,28(39-2)44-29)15-41-26(38)17-8-10-18(32)11-9-17)43-27-24(36)23(35)22(34)21(42-27)14-40-25(37)16-6-4-3-5-7-16/h3-11,19,21-24,27-28,32,34-36H,12-15H2,1-2H3/t19-,21-,22-,23+,24-,27+,28+,29+,30+,31-/m1/s1
SMILES CC12CC(=O)C3CC1(C3(C(O2)OC)COC(=O)C4=CC=C(C=C4)O)OC5C(C(C(C(O5)COC(=O)C6=CC=CC=C6)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   614.2 Volume:   583.938
?
Van der Waals volume.
Dense:   1.052 LogP:   1.502
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.019
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.579
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   32.0
TPSA:   187.51
?
Topological Polar Surface Area.
H-Bond Acceptor:   13.0
H-Bond Donor:   4.0 Rings:   7.0
Heavy Atoms:   13.0

MedChem Properties

QED Drug-Likeness Score:   0.29 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.945 Fsp3:   0.516
MCE-18:   140.426
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.332 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.025
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.556
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.06 Promiscuous compounds:   0.011

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.028 MDCK Permeability:   -5.211
Pgp-inhibitor:   0.056 Pgp-substrate:   0.191
PAMPA:   0.914
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.004
20% Bioavailability (F20%):   0.063 30% Bioavailability (F30%):   0.316
50% Bioavailability (F50%):   0.951

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.008 MRP1:   0.978
Plasma Protein Binding (PPB):   87.335% Volume Distribution (VD):   -0.441
Fu: 15.208%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.037
OATP1B3 inhibitor:   0.982 BCRP inhibitor:   0.007
BSEP inhibitor:   0.987

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.019 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.005 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.017
CYP3A4-inhibitor:   0.003 CYP3A4-substrate:   0.001
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.304
HLM stability:   0.992
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.129 Half-life (T1/2):  1.41

ADMET: Toxicity

hERG Blockers:  0.142 hERG Blockers (10um):  0.713
Human Hepatotoxicity (H-HT):  0.051 Drug-induced Liver Injury (DILI):  0.351
AMES Toxicity:  0.423 Rat Oral Acute Toxicity:  0.155
Maximum Recommended Daily Dose:  0.522 Skin Sensitization:  0.306
Carcinogencity:  0.568 Eye Corrosion:  0.0
Eye Irritation:  0.005 Respiratory Toxicity:  0.011
Drug-induced Neurotoxicity:  0.759 Ototoxicity:  0.824
Hematotoxicity:  0.003 Drug-induced Nephrotoxicity:  0.054
Genotoxicity:  0.423 RPMI-8226 Immunitoxicity:  0.104
A549 Cytotoxicity:  0.048 Hek293 Cytotoxicity:  0.874
BCF:   0.628
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.696
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.377
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.615
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota roots n.a. n.a. PMID[19691309]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT848 Cell line N9 Homo sapiens Inhibition = 106.5 % PMID[12880316]
NPT848 Cell line N9 Homo sapiens Inhibition = 111.0 % PMID[18070958]
NPT848 Cell line N9 Homo sapiens Inhibition = 94.3 % PubChem BioAssay data set
NPT848 Cell line N9 Homo sapiens Inhibition = 80.3 % PMID[19589625]
NPT848 Cell line N9 Homo sapiens IC50 > 100000.0 nM PMID[24871162]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC469419 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9189 High Similarity NPC469417
0.8642 High Similarity NPC469418
0.7952 Intermediate Similarity NPC469420
0.7241 Intermediate Similarity NPC469396
0.7241 Intermediate Similarity NPC469458
0.7241 Intermediate Similarity NPC149002
0.6988 Remote Similarity NPC469448
0.6782 Remote Similarity NPC88176
0.6667 Remote Similarity NPC469421
0.6552 Remote Similarity NPC469422
0.6458 Remote Similarity NPC188217
0.6437 Remote Similarity NPC34066
0.6437 Remote Similarity NPC190862
0.6383 Remote Similarity NPC148185
0.6277 Remote Similarity NPC195114
0.6277 Remote Similarity NPC260300
0.617 Remote Similarity NPC80360
0.6023 Remote Similarity NPC469399
0.593 Remote Similarity NPC478832
0.587 Remote Similarity NPC117943
0.5686 Remote Similarity NPC477617
0.5652 Remote Similarity NPC293568
0.5652 Remote Similarity NPC161626
0.5632 Remote Similarity NPC478831
0.5625 Remote Similarity NPC469398
0.5543 Remote Similarity NPC222102
0.5524 Remote Similarity NPC469397
0.551 Remote Similarity NPC265600
0.5392 Remote Similarity NPC478828
0.5326 Remote Similarity NPC303429
0.5326 Remote Similarity NPC56594
0.5253 Remote Similarity NPC469438
0.5116 Remote Similarity NPC471345
0.5094 Remote Similarity NPC478829
0.5047 Remote Similarity NPC478826
0.5047 Remote Similarity NPC478827

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469419 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data